Related Experiment Video
Updated: Mar 2, 2026

Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue FACS-RTT to Determine the Cellular Origin of Radioactive Signal
Published on: September 10, 2021
TRPC Channels and Alzheimer's Disease.
Rui Lu1, Qian He1, Junfeng Wang2
1Institute of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, China.
Transient Receptor Potential Canonical (TRPC) channels, particularly TRPC6, show involvement in Alzheimer's disease (AD) pathogenesis. Targeting these TRPC channels presents a potential therapeutic strategy for AD.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Alzheimer's disease (AD) is a leading cause of neurodegeneration globally.
- Key AD pathologies include amyloid plaques, tau tangles, and neuroinflammation.
- Emerging evidence implicates Transient Receptor Potential Canonical (TRPC) channels in AD pathogenesis.
Purpose of the Study:
- To review the role of TRPC channels in Alzheimer's disease.
- To explore the specific involvement of TRPC6 in AD development.
- To discuss TRPC channel-based therapeutic strategies for AD.
Main Methods:
- Literature review of studies on TRPC channels and AD.
- Analysis of evidence linking TRPC channel function to AD pathology.
- Evaluation of potential drug targets within the TRPC channel family.
Main Results:
- TRPC channels, especially TRPC6, are implicated in AD pathogenesis.
- Dysregulation of TRPC channels may contribute to calcium homeostasis disruption in AD.
- TRPC channel activity correlates with other AD hallmarks.
Conclusions:
- TRPC channels represent a significant area of research in Alzheimer's disease.
- TRPC6 is a key channel involved in AD progression.
- Targeting TRPC channels offers a promising avenue for novel AD therapeutics.
More Related Videos
06:22A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid
Published on: September 3, 2021
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...